In recent years, China's pharmaceutical source innovation force continues to rise, effectively promoting China from a pharmaceutical power to a pharmaceutical power. In this process, CPHI & PMEC China has gradually developed into an industry bellwether with specialization, internationalization and high-end as its core competitiveness, witnessing the remarkable transformation of China's pharmaceutical industry from "large import and export" to "excellent import and export" in the past few years. Many pioneering enterprises have joined CPHI &PMEC China, drawing their own strategic blueprint in the years of industrial collaboration, and gradually constitute the longitude and latitude lines of the industrial pattern, with a stronger international market competitiveness.

So far, the exhibition has covered 15 subdivisions related to the whole pharmaceutical industry chain, including pharmaceutical raw materials, intermediates and fine chemicals, pharmaceutical excipients, preparations, contract customization, biopharmaceuticals, natural extracts, pharmaceutical machinery, packaging materials, laboratory instruments, environmental protection and cleanliness, etc. For pharmaceutical enterprises to optimize the industrial chain layout, accelerate transformation and innovation to build a two-way platform for deep participation at home and abroad.